Kugiyama K, Inobe Y, Ohgushi M, Morita E, Motoyama T, Ogawa H, Yasue H
Division of Cardiology, Kumamoto University School of Medicine, Japan.
Jpn Circ J. 1998 Jan;62(1):1-6. doi: 10.1253/jcj.62.1.
Pharmacologic stress tests are used to evaluate the significance of coronary arterial stenosis, and adenosine and dobutamine are often used for this purpose. The aim of this study was to examine coronary hemodynamics in 16 patients with stable exertional angina who had organic stenosis (> 90%) in the left anterior descending coronary arteries and in 13 control subjects at baseline and during separate intravenous infusions of dobutamine (20 micrograms/kg per min [corrected]) and adenosine (140 micrograms/kg per min [corrected]). Measurements of great cardiac vein blood flow and lactate and oxygen contents in the blood from the aortic root and great cardiac vein were analyzed in patients with ischemic signs of myocardial ischemia (ST-segment depression in the precordial ECG leads and/or myocardial lactate production) during the infusions (in 11 patients during adenosine infusion and in 12 patients during dobutamine infusion) and in control subjects. Myocardial oxygen consumption during adenosine infusion did not change compared with the baseline in both groups, whereas it increased during dobutamine infusion in both groups (p < 0.01 compared with the baseline in each case). However, great cardiac vein blood flow was significantly increased compared with the baseline during both infusions in both groups (p < 0.01 compared with baseline in each case), and the oxygen contents of great cardiac vein blood, which contains effluent from the ischemic region, showed no decrease but increased significantly during both infusions in the patients in comparison with control subjects. Although the global oxygen supply was excessive, myocardial ischemia occurred during dobutamine and adenosine infusions in the patients. As myocardial oxygen consumption remained unchanged during adenosine infusion, regional myocardial flow reduction, possibly as a result of flow maldistribution, may contribute, at least partly, to adenosine-induced myocardial ischemia. An increase in myocardial oxygen consumption may be the principal cause of myocardial ischemia during dobutamine infusion, but an inappropriate flow increase in normal myocardium may occur during dobutamine-induced ischemia.
药物负荷试验用于评估冠状动脉狭窄的严重程度,腺苷和多巴酚丁胺常用于此目的。本研究的目的是在基线状态以及分别静脉输注多巴酚丁胺(20微克/千克每分钟[校正后])和腺苷(140微克/千克每分钟[校正后])期间,检查16例左前降支冠状动脉存在器质性狭窄(>90%)的稳定劳力性心绞痛患者和13例对照者的冠状动脉血流动力学。在输注过程中(腺苷输注时11例患者,多巴酚丁胺输注时12例患者)以及对照者中,分析了患有心肌缺血缺血迹象(胸前导联心电图ST段压低和/或心肌乳酸生成)的患者的大心静脉血流以及主动脉根部和大心静脉血液中的乳酸和氧含量。腺苷输注期间两组的心肌耗氧量与基线相比均未改变,而两组在多巴酚丁胺输注期间均增加(与各情况下的基线相比,p<0.01)。然而,两组在两种输注期间大心静脉血流均较基线显著增加(与各情况下的基线相比,p<0.01),并且含有缺血区域流出液的大心静脉血液的氧含量在输注期间与对照者相比未降低反而显著增加。尽管整体氧供应充足,但患者在多巴酚丁胺和腺苷输注期间仍发生了心肌缺血。由于腺苷输注期间心肌耗氧量保持不变,局部心肌血流减少(可能是由于血流分布不均)可能至少部分导致了腺苷诱导的心肌缺血。心肌耗氧量增加可能是多巴酚丁胺输注期间心肌缺血的主要原因,但在多巴酚丁胺诱导的缺血过程中正常心肌可能会出现不适当的血流增加。